STOCK MARKET BSE NSE

Centre Plans to Re-launch Jan Aushadi Programme

The idea is to make available quality generic medicines at affordable prices

Published: 04th February 2015 06:00 AM  |   Last Updated: 04th February 2015 03:51 AM   |  A+A-

Centre-Plans

HYDERABAD:  With an intent to offer affordable medicines, the Union ministry of chemicals and fertilizers has embarked on a project to re-launch its Jan Aushadi programme in the next six months.

The intiative, which will be re-introduced under a new name, will mandate all publich health officials to prescribe only unbranded generics falling under the scheme.

‘’It’s (Jan Aushadi) a good initiative but has not been properly implemented. We are working on re-launching the programme under a new name,” said Sudhansh Panth,  Union joint secretary in the department of pharmaceuticals.

Addressing a gathering at the BioAsia 2015 CEO Conclave held at ISB on Tuesday, he said, the idea was to make available quality generic medicines at affordable prices.

As part of the scheme, the government will identify a comprehensive list of essential medicines including pain killers, antibiotics and life-saving drugs. These medicines will be procured by the government from pharmaceutical companies at a price prescribed under the National Pharmaceutical Pricing Authority (NPPA).

Similarly, the government is also working to identify and bring medical devices under the national list of essential devices. “Currently, only 22 medical devices are subject to price monitoring, of which only two devices are under price control. The government is working to identify if some of the devices can be brought under the national list,” said Panth adding that the Drugs & Cosmetics Act, which covers medical devices, was also being amended.

Bringing medical devices under the essential list will help deliver healthcare at affordable prices.

Meanwhile, encouraging pharma companies to follow ethical marketing practices, a Uniform Code of Pharmaceutical Marketing Practices has been finalized after inputs from various stakeholders. “Currently, it’s being practiced voluntarily and we would like to review it in May-June,” he said.

The code of conduct came into effect on January  1 and prevents pharma companies from doling out freebies to doctors in return for prescribing medicines.


Comments

Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.

IPL_2020
flipboard facebook twitter whatsapp